PBI Stock Analysis: Pitney Bowes | NYSE
Integrated Freight & Logistics | NYSE, USA | Market Cap: 2.278m USD | 12M Return: 56.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 48.5M
Qual. Beats: 0
Rev. Trend: -88.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pitney Bowes Inc. (PBI) is a U.S.-based provider of digital shipping solutions, mailing technology, and related financial services, operating globally through two reportable segments: SendTech Solutions and Presort Services. The SendTech Solutions segment supplies physical and digital shipping and mailing hardware, software, supplies, and maintenance, and also offers financing alternatives for third-party equipment purchases - a model that extends the companys revenue stream beyond its own product lines. The Presort Services segment operates as a workshare partner of the United States Postal Service, providing presorted mail processing for commercial mailers in exchange for postal discounts, which is a regulated arrangement tied to USPS workshare programs.
The company distributes through direct and inside sales forces, partner channels, direct mail, and digital channels. Pitney Bowes is classified in the Industrials sector under the Office Services & Supplies sub-industry, a group that has faced secular pressure from the ongoing decline in physical mail volumes as communication and commerce shift digital. Headquartered in Shelton, Connecticut, the company was incorporated in 1920 and trades on the NYSE as a mid-cap stock.
- SendTech shipping solutions revenue pressured by e-commerce competition
- Presort Services revenue declines as USPS mail volume contracts
- Equipment financing portfolio drives SendTech segment margins
| Net Income: 167.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 7.96 > 1.0 |
| NWC/Revenue: -36.72% < 20% (prev -15.22%; Δ -21.51% < -1%) |
| CFO/TA 0.14 > 3% & CFO 455.9m > Net Income 167.4m |
| Net Debt (2.08b) to EBITDA (438.3m): 4.75 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.5m) vs 12m ago -13.69% < -2% |
| Gross Margin: 54.06% > 18% (prev 52.97%; Δ 1.09% > 0.5%) |
| Asset Turnover: 58.49% > 50% (prev 61.13%; Δ -2.64% > 0%) |
| Interest Coverage Ratio: 3.19 > 6 (EBIT TTM 329.4m / Interest Expense TTM 103.2m) |
| A: -0.22 (Total Current Assets 1.13b - Total Current Liabilities 1.82b) / Total Assets 3.15b |
| B: 0.85 (Retained Earnings 2.69b / Total Assets 3.15b) |
| C: 0.10 (EBIT TTM 329.4m / Avg Total Assets 3.21b) |
| D: -0.22 (Book Value of Equity -893.6m / Total Liabilities 4.04b) |
| Altman-Z'' = 1.81 = BBB |
| DSRI: 1.00 (Receivables 642.8m/687.7m, Revenue 1.88b/2.00b) |
| GMI: 0.98 (GM 52.97% / 54.06%) |
| AQI: 1.02 (AQ_t 0.54 / AQ_t-1 0.53) |
| SGI: 0.94 (Revenue 1.88b / 2.00b) |
| TATA: -0.09 (NI 167.4m - CFO 455.9m) / TA 3.15b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 13, 2026, the stock is trading at USD 18.33 with a total of 2,632,510 shares traded. Over the past week, the price has changed by +8.98%, over one month by +5.83%, over three months by +59.44% and over the past year by +56.33%.
Current recommended Stop Loss: 17.60 (which is 4% or 1.2 ATR below the current price).
Pitney Bowes has received a consensus analysts rating of 3.20. Therefore, it is recommended to hold PBI.
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.1 | -6.5% |
P/E Trailing = 16.1731
P/E Forward = 10.9769
P/S = 1.2139
P/B = 9.5693
P/EG = 0.7317
Revenue TTM = 1.88b USD
EBIT TTM = 329.4m USD
EBITDA TTM = 438.3m USD
Long Term Debt = 1.77b USD (from longTermDebt, last quarter)
Short Term Debt = 393.3m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (from shortLongTermDebtTotal, last quarter) + Leases 130.0m
Net Debt = 2.08b USD (calculated: Debt 2.40b - CCE 314.0m)
Enterprise Value = 4.36b USD (2.28b + Debt 2.40b - CCE 314.0m)
Interest Coverage Ratio = 3.19 (Ebit TTM 329.4m / Interest Expense TTM 103.2m)
EV/FCF = 11.17x (Enterprise Value 4.36b / FCF TTM 390.7m)
FCF Yield = 8.96% (FCF TTM 390.7m / Enterprise Value 4.36b)
FCF Margin = 20.82% (FCF TTM 390.7m / Revenue TTM 1.88b)
Net Margin = 8.92% (Net Income TTM 167.4m / Revenue TTM 1.88b)
Gross Margin = 54.06% ((Revenue TTM 1.88b - Cost of Revenue TTM 862.1m) / Revenue TTM)
Gross Margin QoQ = 54.41% (prev 55.05%)
Tobins Q-Ratio = 1.39 (Enterprise Value 4.36b / Total Assets 3.15b)
Interest Expense / Debt = 4.30% (Interest Expense 103.2m / Debt 2.40b)
Taxrate = 26.01% (58.9m / 226.3m)
NOPAT = 243.8m (EBIT 329.4m * (1 - 26.01%))
Current Ratio = 0.62 (Total Current Assets 1.13b / Total Current Liabilities 1.82b)
Debt / Equity = -2.68 (negative equity) (Debt 2.40b / totalStockholderEquity, last quarter -893.6m)
Debt / EBITDA = 4.75 (Net Debt 2.08b / EBITDA 438.3m)
Debt / FCF = 5.33 (Net Debt 2.08b / FCF TTM 390.7m)
Total Stockholder Equity = -723.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.22% (Net Income 167.4m / Total Assets 3.15b)
RoE = -23.14% (negative equity) (Net Income TTM 167.4m / Total Stockholder Equity -723.6m)
RoCE = 31.36% (EBIT 329.4m / Capital Employed (Equity -723.6m + L.T.Debt 1.77b))
RoIC = 14.97% (NOPAT 243.8m / Invested Capital 1.63b)
WACC = 6.91% (E(2.28b)/V(4.68b) * Re(10.84%) + D(2.40b)/V(4.68b) * Rd(4.30%) * (1-Tc(0.26)))
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -26.97 | Cagr: -7.41%
[DCF] Terminal Value 77.97% ; FCFF base≈292.7m ; Y1≈335.6m ; Y5≈493.9m
[DCF] Fair Price = 39.48 (EV 7.43b - Net Debt 2.08b = Equity 5.35b / Shares 135.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: -88.44 | Revenue CAGR: -17.41% | SUE: 0.00 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.33 | Chg30d=+0.00% | Revisions=+38% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.37 | Chg30d=+0.00% | Revisions=+67% | Analysts=6
EPS current Year (2026-12-31): EPS=1.62 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+19.9% | GrowthRev=-2.6%
EPS next Year (2027-12-31): EPS=1.75 | Chg30d=+0.00% | Revisions=+67% | GrowthEPS=+8.1% | GrowthRev=-0.6%
[Analyst] Revisions Ratio: +80% (up=21, down=1)